NOVELTY study finds predicted heterogeneity in asthma and COPD

Clinicians and patients can expect a future shake-up in the labels given to patients currently described as asthma or COPD or to patients with features of both diseases. Baseline characteristics from the NOVEL observational longiTudinal studY (NOVELTY) have already demonstrated the marked heterogeneity within the diseases and considerable overlap between physician-assigned diagnoses of asthma and/or ...

Already a member?

Login to keep reading.

© 2022 the limbic